In this Issue:
Psychiatry
Varenicline and risk of neuropsychiatric adverse events
Identification and management of risk of antenatal psychosocial distress
Complicated depressive illness common in HIV infection
Mortality: an important adverse outcome of severe mental illness
Schizophrenia
Pilot study of MOVE training for negative symptoms in schizophrenia
Effects of antipsychotics, antidepressants and mood stabilisers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Impact of aerobic exercise on BDNF and neurocognition in schizophrenia
Theory of mind in the early course of schizophrenia
Depression
Is impaired reward learning a marker for depression?
Is amygdala reactivity a marker for depression?
SSRI/SSNRIs are modestly effective in paediatric anxiety disorders
Adjunctive pioglitazone is beneficial in bipolar disorder
Neurology
Thrombectomy for acute stroke
Gastrostomy options in patients with ALS
Levetiracetam vs carbamazepine in children
THC doesn’t improve neuropsychiatric symptoms in dementia
Please login below to download this issue (PDF)